MACRA: The Yardstick for Quality that Health Systems Need

yard stickThe number of quality initiatives is rapidly rising in the healthcare industry as stakeholders shift their focus toward the value of patient care. In addition, with the recent implementation of the Medicare Access and CHIP Reauthorization Act (MACRA), the rules surrounding healthcare reimbursement are being rewritten, incentivizing healthcare providers to prioritize the quality of patient visits over the quantity.

Historically, it has been difficult to achieve consensus on defining quality; therefore, it was not consistently measured. MACRA provides tools to assess quality of care, and lays the foundation for a future in which payers and providers must collaborate in new ways driven by patient data.

Continue reading

2019: The Era of Health IT M&A is Coming

Angela BlogOver the last few years, the healthcare industry has undergone an incredible revolution. Mobility solutions deployed across the care continuum are providing higher quality patient care. The shift from fee-for-service to fee-for-value – no matter how the political environment affects the market – is prevailing. Beyond that, innovation and digital tools are supporting this shift. In the U.S. alone, there are more than 6,000 medical device companies. Around 80 percent of them have fewer than 50 employees. Creative solutions to longstanding problems abound.

Continue reading

Looking Ahead in 2016: More Consumerism and Innovation, Less Gadgets, Still Not Enough Interoperability

consumerismWith a new year just getting started, most realists recognize that for all intents and purposes ACA is here to stay. No matter what discourse has transpired or how the next presidential election turns out, we are down a path of value-based care with no turning back. With that in mind, 2016 will see consumers having no other choice but to get more involved in their healthcare spend. Many more people are now insured, and benefit designs increasingly place more burden on the consumer to understand what’s covered, what’s not, and how best to spend their healthcare dollars. With this backdrop, here are four developments I expect to see: Continue reading